Michael Thomas
Physician Assistant · Melbourne, FLNPI 1578514600
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,291 and has fallen 77.6% since, to $290 in 2024.
Across 134 payments — averaging $28.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$650
- Collegium Pharmaceutical, Inc.$424
- Novo Nordisk$349
- Abbott$273
- Boston Scientific$260
- Atricure, Inc.$197
- plus $2K from 25 others
What the payments were for
- Food & beverage$3,65597%
- Education$973%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $650 |
| Collegium Pharmaceutical, Inc. | 23 | $424 |
| Novo Nordisk | 3 | $349 |
| Abbott | 11 | $273 |
| Boston Scientific | 11 | $260 |
| Atricure, Inc. | 1 | $197 |
| Biohaven Pharmaceuticals, Inc. | 5 | $161 |
| Vertos Medical, Inc. | 1 | $145 |
| Medtronic | 4 | $135 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $131 |
| Nevro Corp. | 3 | $118 |
| Foundation Fusion Solutions, LLC | 1 | $116 |
| Stimwave Technologies Incorporated | 7 | $112 |
| Tersera Therapeutics LLC | 4 | $104 |
| Scilex Pharmaceuticals Inc. | 4 | $79 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $55 |
| Curonix LLC | 2 | $43 |
| Adaptive Biotechnologies Corporation | 2 | $41 |
| Almatica Pharma LLC | 2 | $35 |
| Biodelivery Sciences International, Inc. | 2 | $33 |
| Pfizer | 2 | $33 |
| Relievant Medsystems, Inc. | 2 | $32 |
| Lilly USA, LLC | 2 | $29 |
| Radius Health, Inc. | 1 | $27 |
| Indivior Inc. | 1 | $27 |
| Amgen | 2 | $24 |
| Alkermes, Inc. | 1 | $18 |
| West Therapeutics Development, LLC | 1 | $14 |
| GRT US Holding, Inc. | 1 | $14 |
| Pacira Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$217
- NURTEC ODT$216
- SYNERGY ABLATION SYSTEM$197
- mild Device Kit$145
- Superion Indirect Decompression System$125
- RYBELSUS$119
- ETERNA$107
- Ozempic$105
How this compares
$3,752 in reported general payments places this provider in the 85th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 37 | $5,718 |
| Gabapentin | 31 | $583 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $395 |
| Topiramate | 13 | $172 |
| Lisinopril | 20 | $111 |
| Atorvastatin Calcium | 13 | $83 |
| Alprazolam | 13 | $72 |
| Zolpidem Tartrate | 12 | $18 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Melbourne
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
- Nicole HillOrlando$319K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.